0001493152-24-003097.txt : 20240119 0001493152-24-003097.hdr.sgml : 20240119 20240119172254 ACCESSION NUMBER: 0001493152-24-003097 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240117 FILED AS OF DATE: 20240119 DATE AS OF CHANGE: 20240119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Frelick Jeff CENTRAL INDEX KEY: 0001645093 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40899 FILM NUMBER: 24546497 MAIL ADDRESS: STREET 1: 1 FOX RUN LANE, CITY: LEXINGTON STATE: MA ZIP: 02420 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bone Biologics Corp CENTRAL INDEX KEY: 0001419554 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 421743430 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 BURLINGTON WOODS DRIVE, STREET 2: SUITE 100, CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: (781) 552-4452 MAIL ADDRESS: STREET 1: 2 BURLINGTON WOODS DRIVE, STREET 2: SUITE 100, CITY: BURLINGTON STATE: MA ZIP: 01803 FORMER COMPANY: FORMER CONFORMED NAME: Bone Biologics, Corp. DATE OF NAME CHANGE: 20140924 FORMER COMPANY: FORMER CONFORMED NAME: AFH ACQUISITION X, INC. DATE OF NAME CHANGE: 20071127 4 1 ownership.xml X0508 4 2024-01-17 0 0001419554 Bone Biologics Corp BBLG 0001645093 Frelick Jeff C/O BONE BIOLOGICS CORP 2 BURLINGTON WOODS DR. SUITE 100 BURLINGTON MA 01803 0 1 0 0 Chief Executive Officer 0 Common Stock 2151 D Employee Stock Option 3.61 2024-01-17 4 A 0 25000 0.00 A 2024-01-17 2026-01-17 Common Stock 25000 25000 D Employee Stock Option 9540.00 2025-12-27 Common Stock 173 173 D Employee Stock Option 12300.00 2026-05-26 Common Stock 44 44 D Employee Stock Option 892.80 2025-01-01 Common Stock 208 208 D Employee Stock Option 57.60 2025-01-25 Common Stock 157 157 D This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately. This option is fully vested as of the date of this report. /s/ Jeffrey Frelick 2024-01-19